Olorofim activity against multidrug-resistant Fusarium unveils intra-species and inter-species variability
Antimicrobial Agents and Chemotherapy · 2025
DOI: 10.1128/aac.00961-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Ruoning Xue und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Fusarium, Antifungal Agents, Drug Resistance, Multiple, Fungal, Pyrimidines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National High Level Hospital Clinical Research Funding (Interdisciplinary Research Project of Peking University First Hospital).
Abstract (Originalsprache)
Fungi in the genus Fusarium are plant pathogens but are also capable of causing a wide range of diseases in humans. The intrinsic multi-drug resistance of Fusarium often leads to a poor clinical outcome in patients with severe immune disorders. Olorofim, a member of the orotomide class, is a novel type of antifungal drug that interferes with pyrimidine biosynthesis by inhibiting dihydroorotate dehydrogenase and thereby prevents growth and cell division. In this study, the in vitro activity of olorofim was evaluated against 253 Fusarium isolates, of which 228 isolates belonging to the prevalent complexes involved in human infection, F. solani species complex (SC) and F. fujikuroi SC. All Fusarium isolates underwent species-level identification via multi-locus sequence typing (MLST) targeting RPB1 , RPB2 , and TEF1 loci. Antifungal susceptibility testing was performed using a CLSI M38, 3rd ed. broth microdilution for olorofim. The geometric mean of the MICs of olorofim for all 253 isolates was 0.581 µg/mL, ranging from 0.015 µg/mL to >16 µg/mL. Olorofim demonstrated high MICs against F. solani SC, whereas greater potency (lower MICs) was observed against F. fujikuroi SC. Clinical isolates tended to have higher MIC values than environmental isolates, but this pattern was not consistent across all species complexes. Overall, olorofim demonstrated moderate in vitro activity against Fusarium isolates, suggesting it might be a potential candidate for treating fusarioses caused by multidrug-resistant strains.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China.
- Research Center for Medical Mycology, Peking University, Beijing, China.
- National Clinical Research Center for Skin and Immune Diseases, Beijing, China.
- Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
- Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.
- Radboudumc-CWZ Center of Expertise for Mycology, Radboud University Medical Center, Nijmegen, the Netherlands.
ORCID-Profile: Ruoning Xue, Sybren de Hoog, Paul E Verweij, Yinggai Song
Förderung
- National High Level Hospital Clinical Research Funding (Interdisciplinary Research Project of Peking University First Hospital)
Zitieren
APA
Xue, R., Gao, S., de Hoog, S., van Diepeningen, A., Zhou, S., Xu, T., Fokkens, L., Li, R., Bai, L., Wan, Z., Verweij, P. E., & Song, Y. (2025). Olorofim activity against multidrug-resistant Fusarium unveils intra-species and inter-species variability. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00961-25
Vancouver
Xue R, Gao S, de Hoog S, van Diepeningen A, Zhou S, Xu T, et al. Olorofim activity against multidrug-resistant Fusarium unveils intra-species and inter-species variability. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00961-25
BibTeX
@article{Xue2025,
author = {Xue, Ruoning and Gao, Shenghan and de Hoog, Sybren and van Diepeningen, Anne and Zhou, Shaoqin and Xu, Tianyi and Fokkens, Like and Li, Ruoyu and Bai, Lin and Wan, Zhe and Verweij, Paul E and Song, Yinggai},
title = {Olorofim activity against multidrug-resistant Fusarium unveils intra-species and inter-species variability},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
doi = {10.1128/aac.00961-25}
}
EUVIMED